Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16]
Mol Metab
.
2024 Aug:86:101972.
doi: 10.1016/j.molmet.2024.101972.
Epub 2024 Jun 23.
Authors
Joshua Adekunle Babalola
1
,
Anika Stracke
2
,
Tina Loeffler
3
,
Irene Schilcher
3
,
Spyridon Sideromenos
4
,
Stefanie Flunkert
3
,
Joerg Neddens
3
,
Ake Lignell
5
,
Manuela Prokesch
3
,
Ute Panzenboeck
2
,
Herbert Strobl
2
,
Jelena Tadic
6
,
Gerd Leitinger
7
,
Achim Lass
6
,
Birgit Hutter-Paier
3
,
Gerald Hoefler
8
Affiliations
1
D&F Institut für Pathologie Medizinische Universität Graz, Graz, Austria.
2
Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria.
3
QPS Austria GmbH, Grambach, Austria.
4
QPS Austria GmbH, Grambach, Austria; Medical University of Vienna, Vienna, Austria.
5
AstaReal AB, Sweden.
6
Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria.
7
Institute of Molecular Biosciences, University of Graz, Austria.
8
D&F Institut für Pathologie Medizinische Universität Graz, Graz, Austria. Electronic address: Gerald.Hoefler@uniklinikum.kages.at.
PMID:
38925151
PMCID:
PMC11259790
DOI:
10.1016/j.molmet.2024.101972
No abstract available
Publication types
Published Erratum